KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash & Current Investments (2016 - 2026)

AbbVie has reported Cash & Current Investments over the past 14 years, most recently at $5.3 billion for Q4 2025.

  • Quarterly Cash & Current Investments fell 5.36% to $5.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 billion through Dec 2025, down 5.36% year-over-year, with the annual reading at $5.3 billion for FY2025, 5.36% down from the prior year.
  • Cash & Current Investments was $5.3 billion for Q4 2025 at AbbVie, down from $5.7 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $18.1 billion in Q1 2024 and troughed at $5.2 billion in Q1 2025.
  • The 5-year median for Cash & Current Investments is $9.0 billion (2022), against an average of $9.4 billion.
  • Year-over-year, Cash & Current Investments tumbled 76.24% in 2021 and then surged 168.8% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $9.8 billion in 2021, then decreased by 6.11% to $9.2 billion in 2022, then soared by 38.87% to $12.8 billion in 2023, then crashed by 56.66% to $5.6 billion in 2024, then dropped by 5.36% to $5.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Cash & Current Investments are $5.3 billion (Q4 2025), $5.7 billion (Q3 2025), and $6.5 billion (Q2 2025).